LPH-IZKF-J126: Optogenetic tools for restoration of dopaminergic signaling in Parkinsons Disease
FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.09.2026
End date : 28.02.2029
Project details
Scientific Abstract
Optogenetics genetically enabled light-dependent control of neuronal function - has substantial therapeutic potential for neurodegenerative diseases including Parkinsons Disease (PD). This project aims to generate and characterize optogenetic tools enabling light and pathway-specific activation of dopaminergic signalling. Direct targeting of the neuromodulatory circuits and signalling pathways has the potential to overcome some of the current limitations in PD therapy.
Involved:
Contributing FAU Organisations:
Interdisziplinäres Zentrum für Klinische Forschung (IZKF)
Professur für Zelluläre und Molekulare Neurophysiologie
